Escher
Reports
Escher stimulates the reform of the regulatory system for medicines by initiating debate on the future of the medicine development process. Next to its scientific publications, the following policy reports have been produced by Escher to serve this purpose.
- On 18 September Escher published a report on how learning from regulatory practice can help improve the EU marketing authorisation system.
- A regulatory science perspective on adaptive approaches to marketing authorization: Towards appropriate levels of evidence
- Did the U.S. eclipse European pharmaceutical research productivity? An analysis of major reports as searchlights in the fog